# Cocktail Injection Improves Outcomes of FFR Guided PCI

Study · id `cardio:ct-nct02592720` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02592720](<https://clinicaltrials.gov/study/NCT02592720>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02592720

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

## Technical summary

Registry record NCT02592720. Randomized; single masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2017-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT02592720, source copy `cardio:ctgov-nct02592720-2015-10-30`, retrieved 2026-10-31)
- Start date: 2015-10 (registry gives no type) (ClinicalTrials.gov record NCT02592720, source copy `cardio:ctgov-nct02592720-2015-10-30`, retrieved 2026-10-31)
- Primary completion: 2017-10 (anticipated) (ClinicalTrials.gov record NCT02592720, source copy `cardio:ctgov-nct02592720-2015-10-30`, retrieved 2026-10-31)
- Completion: 2017-10 (anticipated) (ClinicalTrials.gov record NCT02592720, source copy `cardio:ctgov-nct02592720-2015-10-30`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02592720, source copy `cardio:ctgov-nct02592720-2015-10-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02592720-2015-10-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Cocktail Injection Improves Outcomes of FFR Guided PCI
- Acronym: CocktailII
- Condition: Acute Coronary Syndromes
- Intervention (Drug): cocktail
- Intervention (Device): FFR
- Intervention (Device): QCA guided group
- Lead sponsor: Xijing Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Xijing Hospital (`cardio:org-xijing-hospital`)

## Provenance

Content hash: 55356c94167870d8e1e3dc1d2cee3d8f4f62f3bb159bf4ec8e32f170ffb02ed2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
